Stay updated on AFM24/SNK01 Combo in EGFR+ Cancers Clinical Trial
Sign up to get notified when there's something new on the AFM24/SNK01 Combo in EGFR+ Cancers Clinical Trial page.

Latest updates to the AFM24/SNK01 Combo in EGFR+ Cancers Clinical Trial page
- Check4 days agoChange DetectedAdded Squamous Cell Carcinoma of Head and Neck as a listed condition and added the Genetic and Rare Diseases Information Center as a resources link.SummaryDifference0.1%

- Check11 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision: v3.4.2 was added. The government-funding notice and Revision: v3.4.1 were removed from the page.SummaryDifference0.4%

- Check61 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center’s current operating status. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check68 days agoChange DetectedCosmetic UI and metadata updates were made, including a glossary toggle label, capitalization changes to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and a revision tag updated to v3.4.0. They do not modify core study content, eligibility, or results.SummaryDifference0.2%

Stay in the know with updates to AFM24/SNK01 Combo in EGFR+ Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AFM24/SNK01 Combo in EGFR+ Cancers Clinical Trial page.